Net Cash Provided by (Used in) Operating Activities |
-337 |
USD |
+98.7% |
Aug 31, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Financing Activities |
454 |
USD |
-98.3% |
Aug 31, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Aug 31, 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
50B |
shares |
0% |
Feb 29, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
1.41B |
shares |
+86.5% |
Feb 29, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Feb 29, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.16K |
USD |
+4704% |
Feb 29, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Aug 31, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
1.4M |
USD |
+11% |
May 31, 2023 |
Q2 2023 |
Cash and Cash Equivalents, Period Increase (Decrease) |
-353 |
USD |
|
Aug 31, 2022 |
Q3 2022 |
Depreciation |
230 |
USD |
-40.9% |
Aug 31, 2023 |
Q3 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.4M |
USD |
+11% |
May 31, 2023 |
Q2 2023 |
Preferred Stock, Shares Issued |
200 |
shares |
0% |
Feb 29, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Feb 29, 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
May 31, 2023 |
Q2 2023 |
Additional Paid in Capital |
14.6M |
USD |
+0.61% |
Feb 29, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
200 |
shares |
0% |
Feb 29, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Aug 31, 2022 |
Q3 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
May 31, 2023 |
Q2 2023 |
Interest Expense |
503K |
USD |
+39.3% |
Feb 29, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Feb 29, 2024 |
Q1 2024 |